Entropy Technologies’s CVS Health CVS Stock Holding History

Entropy Technologies’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-28,146	Closed	-$2.02M	–	1012
2026 Q1	$2.02M	Buy	+28,146	New	+$2.17M	0.09%	283
2025 Q3	–	Sell	-36,699	Closed	-$2.53M	–	872
2025 Q2	$2.53M	Buy	+36,699	New	+$2.41M	0.2%	136
2025 Q1	–	Sell	-116,742	Closed	-$5.24M	–	769
2024 Q4	$5.24M	Sell	116,742 -5,098	-4%	-$286K	0.54%	31
2024 Q3	$7.66M	Sell	121,840 -48,106	-28%	-$2.81M	0.8%	9
2024 Q2	$10M	Buy	+169,946	New	+$10.6M	1.08%	1
2024 Q1	–	Sell	-6,975	Closed	-$551K	–	742
2023 Q4	$551K	Buy	+6,975	New	+$496K	0.1%	321

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Entropy Technologies's CVS Position: Q2 2026 in Review

Entropy Technologies sold out of CVS Health (CVS) in Q2 2026, closing a stake of 28,146 shares — an estimated $2.02M sold.

Entropy Technologies first reported a position in CVS in Q4 2023 and held it in 6 quarters. The position peaked at $10M in Q2 2024. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Entropy Technologies reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
Entropy Technologies sold 28,146 CVS Health shares in Q2 2026, an estimated $2.02M.
Entropy Technologies first reported a position in CVS Health in Q4 2023 and held it in 6 quarters.
Entropy Technologies's CVS Health position peaked at $10M in Q2 2024.
2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.